help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malloy, P. J.
Right arrow Articles by Feldman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malloy, P. J.
Right arrow Articles by Feldman, D.
Endocrine Reviews 20 (2): 156-188
Copyright © 1999 by The Endocrine Society

The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets1

Peter J. Malloy, J. Wesley Pike and David Feldman

Department of Medicine (P.J.M., D.F.), Stanford University School of Medicine, Stanford, California 94305-5103; and Department of Molecular and Cellular Physiology (J.W.P.), University of Cincinnati, Cincinnati, Ohio 45267

I. The Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets (HVDRR)
A. Historical
B. Clinical features of HVDRR
C. Pathophysiology
D. Alopecia
E. 1,25-Dihydroxyvitamin D [1,25-(OH)2D] action and HVDRR
II. Vitamin D Physiology
A. Metabolism
B. 1{alpha}-Hydroxylase deficiency
III. 1,25-Dihydroxyvitamin D Action Mediated by the Vitamin D receptor (VDR)
A. Historical aspects of VDR structure and function
B. The domain structure of the VDR
C. The regulation of gene expression by the VDR
IV. Cellular Basis of HVDRR
A. Studies in cultured skin fibroblasts
B. Studies in other cells
V. The VDR Gene and the Molecular Basis of HVDRR
A. The VDR chromosomal gene
B. The VDR gene promoter
C. Polymorphisms of the VDR gene
VI. HVDRR Mutations Causing the Ligand-Binding Positive Phenotype
A. Initial description of DNA-binding domain (DBD) mutations
B. Characterization of additional DBD mutations
C. Structural analysis of DBD mutations
VII. HVDRR Mutations Causing the Ligand-Binding Negative Phenotype
A. Initial description of ligand-binding domain (LBD) mutations
B. Characterization of additional LBD mutations
C. Structural analysis of LBD mutations
VIII. Additional Mutations In The VDR Gene
A. Hinge region mutations
B. Splice site mutations
C. Major structural mutations
D. Vitamin D resistance without a mutation in the VDR
IX. HVDRR Mouse Model
X. Treatment of HVDRR
A. Vitamin D
B. Calcium
C. Prenatal diagnosis
D. Spontaneous healing of rickets
XI. Analysis, Summary, and Conclusions







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society